tyrosyl-isoleucyl-glycyl-seryl-arginine has been researched along with n-vinyl-2-pyrrolidinone in 1 studies
| Studies (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Trials (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Recent Studies (post-2010) (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Studies (n-vinyl-2-pyrrolidinone) | Trials (n-vinyl-2-pyrrolidinone) | Recent Studies (post-2010) (n-vinyl-2-pyrrolidinone) |
|---|---|---|---|---|---|
| 111 | 0 | 29 | 7,533 | 228 | 2,213 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamada, H; Kawasaki, K; Kodaira, H; Maeda, M; Mayumi, T; Mu, Y; Nomizu, M; Sato, K; Tsutsumi, Y; Yamada, Y | 1 |
1 other study(ies) available for tyrosyl-isoleucyl-glycyl-seryl-arginine and n-vinyl-2-pyrrolidinone
| Article | Year |
|---|---|
Bioconjugation of laminin-related peptide YIGSR with polyvinyl pyrrolidone increases its antimetastatic effect due to a longer plasma half-life.
Topics: Animals; Antineoplastic Agents; Drug Carriers; Drug Delivery Systems; Half-Life; Laminin; Lung Neoplasms; Mice; Neoplasm Transplantation; Oligopeptides; Pharmaceutic Aids; Povidone; Tumor Cells, Cultured | 1999 |